AAAAAA
Results:
1-14
|
Results: 14
Authors:
SILVA JM
MORIN PE
DAY SH
KENNEDY BP
PAYETTE P
RUSHMORE T
YERGEY JA
NICOLLGRIFFITH DA
Citation: Jm. Silva et al., REFINEMENT OF AN IN-VITRO CELL MODEL FOR CYTOCHROME-P450 INDUCTION, Drug metabolism and disposition, 26(5), 1998, pp. 490-496
Authors:
LI C
YERGEY JA
Citation: C. Li et Ja. Yergey, CONTINUOUS-FLOW LIQUID SECONDARY-ION MASS-SPECTROMETRIC CHARACTERIZATION OF PHOSPHOLIPID MOLECULAR-SPECIES, Journal of mass spectrometry., 32(3), 1997, pp. 314-322
Authors:
TRIMBLE LA
CHAURET N
SILVA JM
NICOLLGRIFFITH DA
LI CS
YERGEY JA
Citation: La. Trimble et al., CHARACTERIZATION OF THE IN-VITRO OXIDATIVE METABOLITES OF THE COX-2 SELECTIVE INHIBITOR L-766,112, Bioorganic & medicinal chemistry letters, 7(1), 1997, pp. 53-56
Authors:
DELORME D
DUCHARME Y
BRIDEAU C
CHAN CC
CHAURET N
DESMARAIS S
DUBE D
FALGUEYRET JP
FORTIN R
GUAY J
HAMEL P
JONES TR
LEPINE C
LI C
MCAULIFFE M
MCFARLANE CS
NICOLLGRIFFITH DA
RIENDEAU D
YERGEY JA
GIRARD Y
Citation: D. Delorme et al., DIOXALBICYCLOOCTANYL NAPHTHALENENITRILES AS NONREDOX 5-LIPOXYGENASE INHIBITORS - STRUCTURE-ACTIVITY RELATIONSHIP STUDY DIRECTED TOWARD THE IMPROVEMENT OF METABOLIC STABILITY, Journal of medicinal chemistry, 39(20), 1996, pp. 3951-3970
Authors:
KARGMAN S
WONG E
GREIG GM
FALGUEYRET JP
CROMLISH W
ETHIER D
YERGEY JA
RIENDEAU D
EVANS JF
KENNEDY B
TAGARI P
FRANCIS DA
ONEILL GP
Citation: S. Kargman et al., MECHANISM OF SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN G H SYNTHASE-1 AND SYNTHASE-2 IN INTACT-CELLS/, Biochemical pharmacology, 52(7), 1996, pp. 1113-1125
Authors:
NICOLLGRIFFITH DA
GUPTA N
TWA SP
WILLIAMS H
TRIMBLE LA
YERGEY JA
Citation: Da. Nicollgriffith et al., VERLUKAST (MK-0679) CONJUGATION WITH GLUTATHIONE BY RAT-LIVER AND KIDNEY CYTOSOLS AND EXCRETION IN THE BILE, Drug metabolism and disposition, 23(10), 1995, pp. 1085-1093
Authors:
CHAURET N
LI C
DUCHARME Y
TRIMBLE LA
YERGEY JA
RAMACHANDRAN C
NICOLLGRIFFITH DA
Citation: N. Chauret et al., IN-VITRO AND IN-VIVO BIOTRANSFORMATIONS OF THE NAPHTHALENIC LIGNAN LACTONE 5-LIPOXYGENASE INHIBITOR, L-702,539, Drug metabolism and disposition, 23(1), 1995, pp. 65-71
Authors:
LI C
CHAURET N
DUCHARME Y
TRIMBLE LA
NICOLLGRIFFITH DA
YERGEY JA
Citation: C. Li et al., INTEGRATED APPLICATION OF CAPILLARY HPLC CONTINUOUS-FLOW LIQUID SECONDARY-ION MASS-SPECTROMETRY TO DISCOVERY STAGE METABOLISM STUDIES/, Analytical chemistry, 67(17), 1995, pp. 2931-2936
Authors:
MAMER OA
JUST G
LI CS
PREVILLE P
WATSON S
YOUNG R
YERGEY JA
Citation: Oa. Mamer et al., ENHANCEMENT OF MASS-SPECTROMETRIC DETECTION OF LTC4, LTD4, AND LTE4 BY DERIVATIZATION, Journal of the American Society for Mass Spectrometry, 5(4), 1994, pp. 292-298
Authors:
KARANIAN JW
KIM HY
YERGEY JA
SALEM N
Citation: Jw. Karanian et al., LIPOXYGENASE STIMULATING EFFECTS OF HYDROXYLATED DOCOSAHEXAENOATES PRODUCED BY HUMAN PLATELETS, Prostaglandins, leukotrienes and essential fatty acids, 50(5), 1994, pp. 271-278
Authors:
CALLAGHAN DH
YERGEY JA
ROUSSEAU P
MASSON P
Citation: Dh. Callaghan et al., RESPIRATORY-TRACT EICOSANOID MEASUREMENT USING MICRODIALYSIS SAMPLINGAND GC MS DETECTION/, Pulmonary pharmacology, 7(1), 1994, pp. 35-41
Authors:
PERCIVAL MD
OUELLET M
VINCENT CJ
YERGEY JA
KENNEDY BP
ONEILL GP
Citation: Md. Percival et al., PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN CYCLOOXYGENASE-2, Archives of biochemistry and biophysics, 315(1), 1994, pp. 111-118
Authors:
GROSSMAN SJ
HEROLD EG
DREY JM
ALBERTS DW
UMBENHAUER DR
PATRICK DH
NICOLLGRIFFITH D
CHAURET N
YERGEY JA
Citation: Sj. Grossman et al., CYP1A1 SPECIFICITY OF VERLUKAST EPOXIDATION IN MICE, RATS, RHESUS-MONKEYS, AND HUMANS, Drug metabolism and disposition, 21(6), 1993, pp. 1029-1036
Authors:
NICOLLGRIFFITH DA
CHAURET N
YERGEY JA
TRIMBLE LA
FAVREAU L
ZAMBONI R
GROSSMAN SJ
DREY J
HEROLD E
Citation: Da. Nicollgriffith et al., CHARACTERIZATION OF VERLUKAST METABOLITES ARISING FROM AN EPOXIDE INTERMEDIATE PRODUCED WITH HEPATIC MICROSOMES FROM BETA-NAPHTHOFLAVONE-TREATED RODENTS (P-4501A1), Drug metabolism and disposition, 21(5), 1993, pp. 861-867
Risultati:
1-14
|